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Synthesis and secretome release by human bone marrow
mesenchymal stem cell spheroids within three‐dimensional
collagen hydrogels: Integrating experiments and modelling
Jyotsna Joshi , Mohammadreza Dehghan Abnavi,Chandrasekhar R. Kothapalli

Abstract
Myocardial infarction results in loss of cardiac cell types, inflammation, extracellular
matrix (ECM) degradation, and fibrotic scar. Transplantation of bone marrow‐
derived mesenchymal stem cells (BM‐MSCs) is being explored as they could differentiate into cardiomyocyte‐like cells, integrate into host tissue, and enhance resident
cell activity. The ability of these cells to restore lost ECM, remodel the inflammatory
scar tissue, and repair the injured myocardium remains unexplored. We here elucidated the synthesis and deposition of ECM (e.g., elastin, sulfated glycosaminoglycans,
hyaluronan, collagen type III, laminin, fibrillin, lysyl oxidase, and nitric oxide
synthases), matrix metalloproteinases (MMPs) and their inhibitors (TIMPs), and other
secretome (cytokines, chemokines, and growth factors) in adult human BM‐MSC
spheroid cultures within three‐dimensional collagen gels. The roles of species‐
specific type I collagen and 5‐azacytadine were assessed over a 28‐day period.
Results revealed that human collagen (but not rat‐derived) suppressed MSC proliferation and survival, and MSCs synthesized and released a variety of ECM proteins and
secretome over the 28 days. Matrix deposition is at least an order of magnitude lower
than their release levels at every time point, most possibly due to elevated MMP
levels and interleukins with a concomitant decrease in TIMPs. Matrix synthesis over
the 28‐day period was fitted to a competitive inhibition form of Michaelis–Menten
kinetics, and the production and decay rates of ECM, MMPs, and TIMPs, along with
the kinetic model parameters quantified. Such an integrated experimental and modelling approach would help elucidate the critical roles of various parameters (e.g., cell
encapsulation and delivery vehicles) in stem cell‐based transplantation therapies.
K E Y W OR D S

cardiomyocytes, competitive‐inhibition model, matrix synthesis, mesenchymal stem cells,
Michaelis–Menten kinetics, protein degradation, secretome release

BM‐MSCs, bone marrow‐derived mesenchymal stem cells; VSMCs, vascular smooth muscle cells; MI, myocardial infarction; sGAGs, sulfated glycosaminoglycans; LOX, lysyl
Abbreviations:Q
oxidase; NO, nitric oxide; NOS, nitric oxide synthase; NOS1, neuronal nitric oxide synthase; iNOS, inducible nitric oxide synthase; eNOS, endothelial nitric oxide synthase; bFGF/FGF‐2, basic
fibroblast growth factor; EGF, epithelial growth factor; TGF‐α, transforming growth factor‐alpha; TGF‐β, transforming growth factor‐beta; HGF, hepatocyte growth factor; IGF‐1, insulin‐like
growth factor‐1; VEGF, vascular endothelial growth factor; MMPs, matrix metalloproteases; TIMPs, tissue inhibitor of metalloproteinase; ILs, interleukins; M‐CSF, macrophage colony
stimulating factor; TNF‐α, tumour necrosis factor‐alpha; MCP‐1, monocyte chemoattractant protein; MIP‐1α, macrophage inflammatory protein; RANTES, regulated on activation, normal T‐
cell expressed and secreted; MCP‐3 MCP‐3/CCL7, monocyte‐specific chemokine 3; IP‐10, interferon‐γ inducible protein; TSG‐6, TNFα stimulated gene/protein 6
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I N T RO D U CT I O N

the extent of injury (Altara et al., 2016; Frangogiannis, 2014). Thus,
cardiac tissue regeneration approaches utilizing stem cells, biomaterial

Adult mammalian myocardium comprises cardiomyocytes, fibroblasts,

scaffolds, and growth factors are being explored to replace the lost cell

endothelial cells, smooth muscle cells, stem and progenitor cells, nerve

populations and restore the structure‐function properties of the dis-

endings, and blood cells, with cardiomyocytes alone occupying almost

eased tissue. Human bone marrow‐derived mesenchymal stem cells

75% of myocardial volume (Bowers, Banerjee, & Baudino, 2010;

(HBM‐MSCs) are gaining attention in cardiac therapy due to their abil-

Kapelko, 2001). Myocardial tissue also houses matrix components that

ity to release a wide repertoire of paracrine factors (termed secretome;

contribute to the maintenance of tissue functions during develop-

Ranganath, Levy, Inamdar, & Karp, 2012), which enhances survival and

ment, haemostasis, and disease (Lockhart, Wirrig, Phelps, & Wessels,

function of cardiomyocytes, enables activation, proliferation, and dif-

2011). Myocardial cells uniquely contribute to the turnover of extra-

ferentiation of endogenous cardiac progenitor cells, and inhibits tissue

cellular matrix (ECM), with cardiac fibroblasts producing collagens I

fibrosis (Cashman, Gouon‐Evans, & Costa, 2013; Williams & Hare,

and III, fibronectin, matrix metalloproteinases (MMPs), tissue inhibitors

2011). We had earlier reported that a combination of rat tail‐derived

of MMPs (TIMPs), interleukins (ILs), TGF‐β, TNF‐α, and endothelin,

type I collagen, 5‐azacytidine, and spheroid formation provides an

and cardiomyocytes contributing to collagens IV and VI, laminins,

optimal 3D milieu for the evolution of cardiomyocyte‐like cells from

and proteoglycans (Bowers et al., 2010; Fan, Takawale, Lee, & Kassiri,

HBM‐MSCs (Joshi, Mahajan, & Kothapalli, 2018). However, ECM pro-

2012). Collagens are the most abundant myocardial matrix compo-

tein expression and synthesis and matrix remodelling capabilities of

nents, with type I being the major myocardial structural protein consti-

these cells remain relatively unknown, which is critical for their appli-

tuting 75–80% of the total collagen (LeGrice, Pope, & Smaill, 2005).

cations in situ post‐MI.

Apart from type I, type III collagen constitutes 15–20% and forms fine

This study is based on the hypothesis that HBM‐MSC survival,

pericellular network, whereas minor amounts of other collagen types

proliferation, ECM synthesis, and secretome release is regulated by

form basement membrane (e.g., collagen IV) or found in the cardiac

3D scaffold source (rat vs. human collagen), aza exposure (10 μM),

interstitium with linkages to other collagens (collagens V and VI;

and culture duration (over 28 days). This study is also partially driven

LeGrice et al., 2005). In addition to collagens, proteoglycans, glycopro-

by immune concerns over the utility of animal‐derived collagen gels

teins, elastin, fibronectin, and laminin also play a major role in cell

for clinical applications (Gorgieva & Kokol, 2011). Finally, the time‐

matrix organization (Bowers et al., 2010). Elastin is found in the walls

dependent evolution of protein synthesis and degradation (i.e., remod-

of blood vessels and in the cardiac interstitium and plays a role in tis-

elling) within these cultures, mediated by MMPs (enzyme) and TIMPs

sue organization, strength, and elasticity (Fomovsky, Thomopoulos, &

(inhibitor), was fitted to a competitive inhibition form of Michaelis–

Holmes, 2010). Elastin biosynthesis involves release of soluble

Menten reaction kinetics and the model parameters elucidated.

tropoelastin monomers that aggregate and mature on microfibrillar
scaffolds composed mainly of fibrillin, with LOX mediating the cross‐
linking, stability, and assembly of tropoelastin monomers (Kielty,

2

MATERIALS AND METHODS
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Sherratt, & Shuttleworth, 2002).
Other glycoproteins (thrombospondins and tenascins), proteogly-

2.1
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Preparation of collagen hydrogels

cans (versican and biglycan), and GAGs (hyaluronan, heparin, heparin
sulfate, chondroitin sulfate, dermatan sulfate, and keratin sulfate) con-

Type 1 rat collagen extracted and purified from rat tail tendon

tribute to the nonstructural component of the myocardial matrix.

(Corning®) and type 1 human collagen extracted and purified from

GAGs and proteoglycans also aid in matrix hydration and tissue plas-

neonatal foreskin derived‐fibroblast cultures (Vitrocol®; Advanced

ticity needed for cell migration, proliferation, and cardiac contractility

Biomatrix) were used to form 2 mg/mL gels, by adjusting the amounts

(Pelouch, Dixon, Golfman, Beamish, & Dhalla, 1993; Rienks,

of stock collagen, NaOH, 10× PBS, and culture media, as per vendor's

Papageorgiou, Frangogiannis, & Heymans, 2014). Nitric oxide (NO)

protocol.

generated from NO synthase (NOS) plays crucial role in cardiac muscle
contraction, and all three isoforms of NOS (NOS1, NOS2 [iNOS], and
NOS3

[eNOS])

are

present

distinctly

within

cardiomyocytes

2.2 | Human BM‐MSC culture and spheroid
formation

(Förstermann & Sessa, 2011). Thus, myocardial ECM is a dynamic
and intricate assembly of multiple matrix components and a rich store-

Cryopreserved Poietics™ normal HBM‐MSCs (PT‐2501), isolated from

house of bioactive molecules that essentially mediate cell signalling,

adult human bone marrow of the posterior iliac crests, were obtained

matrix synthesis, and degradation processes via autocrine or paracrine

from Lonza (Walkersville, MD, USA). The cells were cryopreserved

mechanisms (Spinale, 2007).

after the second passage and had ≥90% of CD105, CD166, CD90,

In severe cases of myocardial infarction (MI), there could be loss of

CD44, and CD73. HBM‐MSC spheroids were formed using a hanging

up to 50 g of cardiac tissue with a concomitant loss of millions of

drop method, from three to six passage cells, using Gibco™ DMEM. In

cardiomyocytes per gram of tissue (Zimmermann et al., 2006). To mit-

brief, loose cells were trypsinized, neutralized, centrifuged at 500 rcf

igate such loss, the cardiac intrinsic repair follows soon after cardio-

for 5 min, and suspended in DMEM culture media. Cell suspensions

myocyte death, but the outcome is usually adverse and varies with

(~1,000 cells/20 μl) were pipetted into the lids of Petri plates that

were inverted and placed over Petri dishes containing PBS, followed

determined to account for the baseline of protein amounts within cell

by a 24‐hr incubation under standard aseptic culture conditions. After

pellet samples in respective hydrogels.

1 day of incubation, hanging drops were gently transferred on tissue
culture plastic (TCP) or sandwiched within rat or human collagen

2.3.3
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sGAG assay

hydrogels. Cell‐loaded hydrogels were incubated under standard culture conditions to induce their gelation prior to adding culture media

The total sGAGs deposited within the cell layers and that released in

supplemented with and without 10 μM aza. Rat collagen took ~30

the pooled media were quantified using a quantitative dye‐binding

min, whereas human collagen took ~90 min to gel, matching the ven-

sGAG assay (Kamiya Biomedical Company), and the processed sam-

dor's specifications. Media was changed in all cultures every 48 hr

ples were read at 610 nm using a microplate reader. A standard curve

over the 28‐day period, including replenishing fresh aza. TCP cultures

generated from the sGAG samples provided with the kit was used to

did not receive aza and act as a baseline for each quantified measure

calculate sGAG amounts in each test sample.

and for comparing with 3D cultures.

2.3.4
2.3

Biochemical assays for matrix quantification

|

Proteins released into the pooled media and those deposited in the
cell layers at Days 1, 12, and 28 of cultures were quantified in all test
conditions. The pooled spent culture media was collected and stored
at −20°C, transferred to Eppendorf safe‐lock tubes, and centrifuged
at 14,000 rpm for 15 min at 4°C. The supernatant was discarded,
and the pellet homogenously suspended in distilled deionized water
for biochemical analyses. The deposited matrix proteins within the cell
layers were harvested from the cultures at various time points. The
cultures were first rinsed with 1× PBS, trypsinized for cell‐laden gel
detachment from the plates, neutralized with culture media, pipetted
into Eppendorf safe‐lock tubes, and centrifuged at 500 rcf for 5 min.
The supernatant was discarded, and the cell pellet was homogenously
suspended in distilled deionized water and stored at −20°C for biochemical analyses.

|

HA assay

The hyaluronic acid amounts deposited within cell layers and in the
pooled media were quantified using a quantitative enzyme‐linked
immunoassay (HA‐ELISA assay kit, Echelon, Salt Lake City, UT). Absorbance was measured at 403 nm using a microplate reader, and the
standard curve generated was used to find HA levels in the test
samples.

2.3.5

|

Fastin assay for elastin protein

The total elastin deposited within the cell layers (i.e., matrix elastin)
and that released in the pooled media (i.e., tropoelastin) was quantified
using a Fastin™ elastin assay (Accurate Chemical and Scientific Corp;
Westbury, NY). The assay is based on the principle that the dye
reagent, TPPS (5,10,15,20‐teraphenyl‐21H,23H‐porphyrine), has an
affinity to bind with solubilized elastin. Absorbance was measured
using the microplate reader at 513 nm, and a standard curve was generated to quantitate elastin in the samples.

2.3.1

|

DNA assay
2.3.6

|

LOX functional activity

The total double‐stranded DNA was quantified using DNA quantification kit (Sigma‐Aldrich), which is based on a fluorescent dye

LOX activity in the cell matrix and in the pooled media was deter-

bisbenzimide H33258 (Hoechst 33258). Samples were excited at

mined using a sensitive fluorescence‐based assay (Amplex® Red

360 nm, and the fluorescence emissions at 460 nm were recorded

Hydrogen Peroxide/Peroxidase assay kit, Molecular Probes) that uses

using a microplate reader (Biotek Synergy H1m). A calibration curve

the Amplex Red reagent (10‐acetyl‐3,7‐dihydroxyphenoxazine) to

was prepared using DNA concentration of the standards provided

detect H2O2. This assay is based on the principle that LOX amount

with the kit versus their respective fluorescence intensities. The least

is proportional to the released H2O2 because LOX oxidatively deami-

squares regression equation was fitted for this curve, which was used

nates alkyl monoamines and diamines (Palamakumbura & Trackman,

to determine the DNA amounts in the samples. Total cell density in

2002; Simmers, Gishto, Vyavahare, & Kothapalli, 2015). Absorbance

each sample was calculated assuming 8.5 pg DNA per cell (Wang,

was read at 560 nm, and a linear standard curve was derived to find

Tran, Seshareddy, Weiss, & Detamore, 2009).

H2O2/LOX in the samples.

2.3.2

2.4

|

BCA assay

|

Secretome release

Total protein released into pooled media and deposited within cell cul-

The cytokine/chemokine/growth factor cocktail pertinent to cardio-

tures was quantified using PierceTM BCA protein assay kit. The absor-

myocyte differentiation and cardiac tissue regeneration was quantified

bance in processed samples was read at 562 nM using a microplate

using Discovery Assays® (Eve Technologies, Alberta, Canada) accord-

reader, and the total protein in samples was determined using the least

ing to the manufacturer's protocol. Briefly, the collected pooled media

squares regression equation from standard curve generated from BSA

from cell cultures was thawed on ice, centrifuged, and required vol-

standards provided in the kit. Total protein in cell‐free hydrogels was

umes aliquoted into 0.5‐ml polypro snap‐cap tubes. Nine essential

metalloproteases and their inhibitors (MMPs and TIMPs, respectively)

cultures at all corresponding time points (p < .05). However, aza pres-

were quantified using human MMP and TIMP panel assay (assay sen-

ence did not impact cell viability in human collagen cultures.

sitivity: 0.5–14 pg/ml); 42 essential cytokines/chemokines quantified
using human cytokine array/chemokine array assay (assay sensitivity:
0.5–10 pg/ml); and TGFβ‐1, 2, and 3 quantified using TGF‐β array
(assay sensitivity: 2–6 pg/ml). These assays utilize multiplexing LASER
bead technology where fluorophore beads provide a platform for multiple cytokine and chemokine detection from a single assay using the
bead analyser (Bio‐Plex 200).

3.2 | Cell proliferation and matrix synthesis in 2D
cultures
The average cell density increased from 3,100 to 7,800 (p < .05;
Figure 2a), with a simultaneous increase in average normalized total
matrix protein deposition (~6,300 pg to ~26 ng; p = .0002; Figure 2
c), from Days 12 to 28. Although average normalized total protein

2.5

|

IF labelling and imaging

release in media increased from Days 1 to 12 (~280 to 990 ng; p < .05;
Figure 2d), it decreased from Days 12 to 28 (~990 to 380 ng, p =

Primary antibodies (Santa Cruz Biotechnology) for collagen type III,
laminin, fibrillin, NOS2, and NOS3 deposited by the MSC spheroids
were assessed in 28‐day culture conditions. Cell‐laden hydrogels were
fixed and stained with antibodies and DAPI at the end of each culture
period (Joshi et al., 2018). Live/Dead® Viability/Cytotoxicity Kit
(Molecular Probes) was used to determine the cell viability and toxicity
at various culture conditions (Gishto, Farrell, & Kothapalli, 2015). All
fluorescence images were acquired using Zeiss Axiovert A1 florescence microscope equipped with Hamamatsu camera and an image
acquisition software. Multiple images from at least three independent
wells were analysed for each case.

.0029). The normalized LOX deposition increased from Days 1 to 12
(~150 to 270 pM) and lowered by Day 28 (~100 pM, p < .05); similarly,
normalized LOX activity in pooled media increased from Days 1 to 12
(~8 to 11 nM; p < .05) but reduced from Days 12 to 28 (~11 to 4.7 nM;
p < .0001; Figure 2b). Although normalized sGAG and elastin matrix
deposition slightly increased from Days 1 to 12, it reduced from Days
12 to 28 (~365 and 280 pg to ~30 and 90 pg; p = .01; Figure 2c). On
the other hand, normalized sGAG and tropoelastin release into media
increased from Days 1 to 12 (~650 and 880 pg to ~3,300 and 2,700
pg, respectively; p = .004; Figure 2d) and plateaued from Days 12 to
28. Normalized HA in matrix reduced from Days 1 to 12 (~36 to 18
pg; p < .001; Figure 2c) and from Days 12 to 28 (~18 to 7 pg; p <

2.6

|

Western blots

.0001); however, HA release into pooled media increased with culture
duration from Days 1 to 12 (~38 to 65 pg; p = .0225; Figure 2d). In gen-

SDS/PAGE western blot analysis was performed for semiquantitative

eral, levels of total protein, LOX, elastin, and GAGs were orders of

analysis of collagen type III, laminin, fibrillin, NOS2, and NOS3 proteins

magnitude higher in pooled media compared with that deposited as

(Simmers et al., 2015). Blots were performed for both the released

matrix. Moreover, elastin and sGAG levels were similar in matrix or in

proteins in pooled media and that deposited within the cell layers,

pooled media and orders of magnitude higher than HA levels. These

using samples specified in Section 2.3. Band intensities were normal-

values establish the baseline for various ECM proteins synthesized

ized to total protein amounts (BCA assay) and further to cell densities

and released within 2D MSC cultures in the absence of exogenous aza.

within respective culture conditions.

2.7

|

Statistical analysis

All data were represented as mean ± standard error of n ≥ 3 wells per
condition, with at least three independent replicates. Statistical analysis was performed using GraphPad Prism 5 for Student's t test, one‐
way analysis of variance (ANOVA) followed by Tukey's test, or two‐
way ANOVA followed by Bonferroni post hoc test, to find the statistical significance and determine the pairs of groups that were significantly different (p < .05).

3.3 | MSC proliferation, protein release, and
deposition within rat collagen gels
Within rat collagen, the average cell density in controls (0 μM aza)
increased steadily with culture duration (~3,000, 7,500, and 1,700
for Days 1, 12, and 28, respectively; p = .04; Figure 2e). Normalized
LOX deposition in matrix increased in controls over time (from ~150
to 400 pM; p = .02 for Day 1 vs. Day 28; Figure 2f), although LOX
release in pooled media steadily reduced with culture duration
(~7,900 to 1,900 pM; p < .05). Normalized total protein and sGAG
deposition in controls increased from Days 1 to 12 but decreased by

3

RESULTS

|

Day 28 (~55 ng and 325 pg on Day 12 to ~12 ng and 83 pg on Day
28, respectively; p < .001; Figure 2g), whereas the total protein and

3.1

|

Cell viability in rat and human collagen gels

sGAG release into media stayed steady throughout the culture period
(Figure 2h). HA deposition in matrix and release into pooled media, on

Cell viability within rat collagen cultures were ≥80% in all culture con-

a per cell basis, lowered by Day 12 (~8 and 20 pg) and Day 28 (~5 and

ditions and were not influenced by aza treatment (Figure 1). On the

16 pg) in control cultures, compared with Day 1 (~36 and 38 pg; p <

contrary, viability ranged between 50% and 60% in human collagen

.001 in both cases). Although normalized elastin matrix deposition

cultures and was significantly lower compared with that in rat collagen

reduced in controls from Day 1 (~140 pg) to Day 12 (~65 pg) and from

FIGURE 1 Schematic of the MSC evolution in 2D and 3D cultures over a 28‐day culture period (Joshi et al., 2018): cell spheroids seeding on Day
0, undifferentiated MSC identification on Day 1, MSC differentiation to cardiac progenitor cells on Day 12, and mature cardiomyocytes formation
by Day 28. Respective cell markers used at each time point were also shown. (a) Representative immunofluorescence images from LIVE/DEAD®
staining within rat or human collagen gels, on Days 1, 12, and 28, in the presence or absence of 10 μM aza. Scale bar: 50 μm. Quantification (mean
± standard error) of the cell viability from these images in rat (b) and human (c) type I collagen gels [Colour figure can be viewed at
wileyonlinelibrary.com]

Days 12 to 28 (undetectable; p < .0001; Figure 2g), tropoelastin

aza‐treated cultures over the 28‐day period (Figure 2g,h). Although

release increased steadily over the culture duration (p = .001 for

elastin matrix amounts decreased with culture duration in aza‐treated

D12 [~1,000 pg] vs. D28 [~1,500 pg]; Figure 2h).

samples (~140 pg on Day 1 to ~25 pg on Days 12 and 28; p < .05; Fig-

The overall average cell density in aza‐treated cultures increased

ure 2g), tropoelastin release improved with culture duration (p < .0001

from Days 1 to 28 (p < .1 for D1 with ~3,400 vs. D28 with ~10,000;

for D1 [~850 pg] vs. D28 [3,000 pg]; Figure 2h). Finally, normalized

Figure 2e). Normalized total protein matrix deposition in aza‐treated

LOX deposition in matrix steadily increased with culture duration, with

samples (Figure 2g) increased from Days 1 to 12 (~6 to 14 ng; p <

significantly higher amounts on Day 28 (~1,200 pM) versus Days 1

.05) and furthermore from Days 12 to 28 (~14 to 50 ng; p < .0001).

(~150 pM) and 12 (~270 pM; p = .001; Figure 2f); however, LOX

The normalized total protein release in pooled media reduced from

release into pooled media reduced over the 28‐day period (~8,000

Days 1 to 12 (~275 to 117 ng; p < .01; Figure 2h) but increased from

pM on Day 1 vs. ~3,200 pM on Day 28; p < .05; Figure 2f). In general,

Days 12 to 28 (~117 to 480 ng; p < .001). Normalized sGAG deposi-

(a) the total protein, LOX, elastin, and GAG amounts in pooled media

tion in aza‐treated cultures reduced with culture duration (Figure 2

were much higher than that in matrix, in both controls and aza cul-

g), although sGAG release into pooled media remained constant over

tures, (b) aza‐receiving cultures had lower levels of ECM proteins in

the culture duration (Figure 2h). Similarly, an overall reduction in HA

both matrix and media at Day 12 (vs. controls), but higher levels by

deposition as matrix and release into pooled media was noted in

Day 28, and (c) elastin and sGAG levels were comparable in all the

FIGURE 2 (a) Average cell density in TCP cultures over 28 days. (b) Normalized amounts of LOX activity in matrix and pooled media within TCP
cultures over 28 days. Normalized levels of total protein, elastin, sGAG, and HA deposited as matrix (c) or released into pooled media (d), over 28
days in TCP cultures. All TCP cultures were in the absence of aza. Data were represented as average ± standard error. (e) Average cell density in rat
tail‐derived 3D collagen gels, over 28 days, with and without 10 μM aza. (f) Normalized amounts of LOX activity in matrix and pooled media within
rat tail‐derived 3D collagen gels over 28 days, with and without aza. The proteins deposited in matrix (g) or released into pooled media (h) over 28
days within rat tail‐derived 3D collagen gels, with and without aza. Data were represented as mean ± standard error. (i) Average cell density in type
I human collagen gels, over 28 days, with and without 10 μM aza. (j) Normalized amounts of LOX activity in matrix and pooled media within human
collagen gels over 28 days, with and without aza. The proteins deposited in matrix (k) or released into pooled media (l), at various time points over
28 days, in the absence or presence of 10 μM aza, in human 3D collagen gels. Data were represented as mean ± standard error [Colour figure can
be viewed at wileyonlinelibrary.com]

culture conditions at all time points, and significantly higher than cor-

presence in pooled media progressively increased over the 28 days

responding HA amounts.

(~40 pg on Day 1 to ~420 pg on Day 28; p = .0003; Figure 2l). Normalized elastin deposition as matrix steadily and significantly decreased
with culture duration in controls (~140 pg on Day 1 and undetectable

3.4
MSC proliferation, ECM release, and deposition
within human collagen gels
|

on Day 28; p = .0004; Figure 2k), but elastin release progressively
increased with culture duration (~900 pg on Day 1, 6,500 pg by Day
12, and 23 ng by Day 28; p < .0001; Figure 2l).

The average cell density decreased with culture duration in controls

Average cell density in aza‐treated cultures increased initially (p <

(~3,000, 2,000, and 1,500 on Days 1, 12, and 28, respectively); how-

.05 for D1 with ~3,000 vs. D12 with ~6,700) but reduced to Day 1

ever, the differences were not statistically significant (Figure 2i). Com-

levels by Day 28 (p < .001 for D12 vs. D28) within human collagen

pared with Day 1 levels, overall LOX amounts improved with culture

gels (Figure 2i). Normalized total protein deposition and release into

duration, in both matrix and pooled media (p = .04 and p = .001,

pooled media within aza cultures increased progressively during the

respectively; Figure 2j). The normalized total protein deposition as

culture period (p < .001 in all cases; Figure 2k,l). Normalized sGAG

matrix increased in controls from Day 1 to Day 12 (~6.3 to 250 ng;

amounts were undetectable in matrix at Days 12 and 28 within aza

p < .001; Figure 2k) but reduced from Day 12 to Day 28 (~250 to

cultures but increased in pooled media from Day 12 to Day 28 (470

100 ng; p < .05). Normalized total protein release in controls increased

to 2,500 pg; p < .001; Figure 2l). HA deposition in matrix remained

progressively from Day 1 to Day 28 (~270 ng to 6 μg; p = .0062;

unchanged by Day 28 (p > .05 for D1 vs. D28; Figure 2k), whereas

Figure 2l). sGAG deposition and release in control cultures was only

its release in pooled media increased multifold (p < .0001 for D1 with

detectable at Day 28 (Figure 2k,l). Although HA deposition as matrix

~40 pg vs. D28 with 256 pg) within aza cultures. Normalized elastin

did not significantly change with culture duration in controls, its

deposition dropped in aza‐treated samples with culture duration (p <

.0001 for D1 [140 pg] vs. D28 [undetectable]), whereas elastin release
increased with culture duration (p < .0001 for D1 [~870 pg] vs. D28

3.5 | Immunofluorescence labelling and western blot
analysis of ECM proteins

[16.5 ng]; Figure 2l). LOX deposition and release increased with culture duration till Day 12 (p = .0445 and p = .0003, respectively) in

The presence of type III collagen, laminin, fibrillin, NOS2, and NOS3 in

aza cultures, after which it plateaued (Figure 2j). Taken together, (a)

2D and 3D controls and aza‐receiving cultures, at various time points,

the total protein, LOX, elastin, and GAG amounts in pooled media

was

were much higher than that in matrix, in both controls and aza cul-

(Figure 3) and quantified from western blot analysis (Figure 4). The

tures, (b) aza‐receiving cultures had lower levels of ECM proteins in

western blot band intensities were first normalized to total protein

both matrix and media at Day 12 (vs. controls), but similar levels by

amounts (BCA assay) and further to cell densities within respective

Day 28 (vs. controls), and (c) elastin and sGAG levels were comparable

cultures. All five proteins were detectable in cell matrix within rat or

in all the culture conditions at all time points, and significantly higher

human collagen gels from Day 12, with none detectable in Day 1 cul-

than corresponding HA amounts.

tures from images and western blots. Human collagen gels (both

qualitatively

visualized

from

immunofluorescence

images

FIGURE 3 Representative immunofluorescence images of cardiac extracellular matrix proteins (collagen type III, laminin, and fibrillin) and nitric
oxide synthases (NOS2 and NOS3) in cultures within 2D TCP and 3D rat or human collagen gels, at various time points over 28 days, in the
presence or absence of 10 μM aza. Scale: 100 μm [Colour figure can be viewed at wileyonlinelibrary.com]

FIGURE 4 Quantification of bands from western blot analysis of ECM proteins (collagen type III, laminin, and fibrillin) and nitric oxide synthases
(NOS2 and NOS3), isolated from (a) cell matrix and (b) pooled media. The intensity from western blot bands was normalized to the intensity of
total protein expressed and further to the cell count in respective cases. Representative gel bands were shown for each protein at respective time
points (D1, D12, and D28) [Colour figure can be viewed at wileyonlinelibrary.com]

FIGURE 5 Heat maps showing the amounts of various MMPs, TIMPs, and cytokines quantified using LASER bead technology (Eve Technology)
within (a) TCP, (b) 3D type I rat collagen cultures, and (c) 3D type I human collagen cultures, under different conditions over 28 days [Colour figure
can be viewed at wileyonlinelibrary.com]

controls and aza‐exposed) promoted deposition of collagen type III,

cultured on TCP for 28 days. MIP‐1α was not expressed within rat col-

NOS2, fibrillin, and laminin within matrix layers (Figure 4a), by Day

lagen gels but was faintly released in TCP and human collagen gels.

28, compared with other gel types. The presence of aza did not pro-

Finally, CX3CL1 and MDC (CCL22) were not significantly influenced

mote significant deposition of any of these proteins compared with

by scaffold type, aza exposure, or culture duration. These results sug-

control cultures, in both human and rat collagen gels. Qualitatively,

gest that spheroid formation, 3D collagen gels, collagen source (human

the percentage of cells that stained positive for NOS3 in all culture

vs. rat), and aza strongly influenced the release of MCP‐1, VEGF, IL‐6,

conditions was significantly higher compared with those for other pro-

IL‐8, and FGF‐2.

teins (Figure 3). Interestingly, western blot analysis of these proteins

The basal MMP‐1 levels in TCP were increased in 3D collagen (rat

from pooled media aliquots (Figure 4b) suggested that collagen type

or human), although the amounts were lowered by more than half

III, laminin, and fibrillin release improved by Day 12 in only TCP and

with aza‐treatment. MMP‐2 was profusely expressed in all cultures,

human collagen gel cultures, and the amounts of these proteins either

with the highest in TCP and the lowest within human collagen cul-

remained stable or reduced by Day 28 in most of the culture condi-

tures. Interestingly, within rat collagen gels, MMP‐2 levels reduced

tions except in human collagen gels.

by Day 12 (with or without aza) but increased by Day 28. MMP‐3
levels remained low in all cultures, MMP‐7 levels varied based on substrate type (TCP < rat collagen gel < human collagen gel), whereas

3.6
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Secretome analysis

MMP‐8 levels were the least in human collagen gels followed by rat
collagen gels and TCP. Although MMP‐9 levels were low in all cultures,

Out of the 42 cytokines quantified (Figure 5; Data S1), eotaxin‐1 and

they significantly varied depending on culture conditions and duration.

IL‐15 were not expressed at all; EGF, TGF‐α, Flt‐3L, GM‐CSF, IFN‐α2,

MMP‐10 levels were low, whereas MMP‐12 was not expressed in all

IL‐10, IL‐12 (p40), IL‐12 (p70), PDGF‐AA, IL‐13, PDGF‐BB, CD154,

cultures. Finally, MMP‐13 amounts were highly influenced by sub-

IL‐17A, IL‐1RA, IL‐1α, IL‐1β, IL‐2, IL‐3, IL‐5, IL‐7, MIP‐1B, RANTES,

strate type, aza treatment, and culture duration.

TNF‐α, TNF‐β, IL18, and IL‐4 were the least expressed (≤5 pg/ml);

TIMP‐1 expression was abundant in all cultures, and the amounts

FGF‐2 (bFGF), Fractalkine/CX3CL1, GRO‐α, MCP‐3/CCL7, CCL22,

were almost 10‐fold higher in 2D compared with 3D cultures. TIMP‐

IP‐10/CXCL10, and MIP‐1α were moderately expressed (≤100

2 levels were also high in all cultures (TCP > rat collagen > human col-

pg/ml); IL‐6, IL‐8, and VEGF‐α were highly expressed (100‐600

lagen) by Day 28. Although TIMP‐3 was high in TCP cultures (loose or

pg/ml); and MCP‐1 was profusely expressed (<2,000 pg/ml). Similarly,

spheroids) at all time points, it was in intermediate levels in rat colla-

of the three cytokines quantified using TGF‐β‐Plex Discovery Assay,

gen gels and surprisingly was almost non‐existent in human collagen

TGF‐β1 was highly expressed (350–450 pg/ml), TGF‐β2 was moder-

gels. In general, aza showed inhibitory effect on TIMPs‐1, 2 and 3

ately expressed (≤100 pg/ml), and TGF‐β3 was the least expressed

released within rat and human collagen gels. Taken together, these

(≤2 pg/ml) in all culture conditions. Finally, of the 13 cytokines quanti-

results suggest that 3D spheroid formation, 3D cultures, collagen

fied using MMP 9‐Plex and TIMP 4‐Plex Discovery Assays, MMPs 1, 3,

source, and aza exposure directly influence levels of MMPs‐1, 2, 3,

7, 8, 9, 10, and 12 were mostly within 0–200 pg/ml range, MMPs 2 and

7, 8, 9, and 13 and TIMPs‐1, 2, 3, and 4 releases (Figure 5).

13 were within 1,000–12,000 pg/ml range, TIMP‐4 was less than 50
pg/ml, and TIMPs 1, 2, and 3 were in a broad range (0–80,000 pg/ml).
We further interpreted the release of these cytokines based on
culture conditions as well as categorized into growth factors,

3.7 | Global analysis of protein deposition and
degradation

chemokines, and proteases/inhibitors. TGF‐β1, β2, and β3 levels did
not vary significantly with culture conditions. VEGF‐α amount was

Thus far, the levels of matrix proteins and secretome synthesized and

the highest in loose MSCs that reduced in spheroids on TCP by Day

released by cells were quantified and compared based on the culture

28 but increased upon aza exposure in 3D rat or human collagen cul-

conditions (aza presence, 2D vs. 3D culture, collagen species source,

tures. Fibrotic cytokine FGF‐2 amount was also the highest in loose

and culture duration). However, it would be more beneficial to gain

MSCs on TCP, followed by spheroids in TCP, but lower within 3D col-

a generalized mechanistic understanding of the relationship between

lagen cultures (Figure 5). Potent inflammatory cytokine MCP‐1 levels

matrix synthesis/deposition and factors contributing to that (role of

drastically reduced in rat and human collagen gels by Day 12 but

matrix degrading and protecting enzymes). Thus, we pooled the nor-

increased within rat collagen by Day 28 in the presence or absence

malized protein (total protein, elastin, GAGs, and LOX) amounts

of aza. However, MCP‐1 amount in human collagen cultures stayed

deposited as matrix or released into media, as quantified from various

the same from Day 12 to Day 28 and was further reduced by aza‐

assays (Figure 2), from all culture conditions (2D and 3D, 0 and 10 μM

treatment. IL‐6 and MCP‐1 levels significantly reduced within rat col-

aza) tested in our study to identify respective time‐dependent global

lagen by Day 12, but increased by Day 28; however, their levels

trends. A modest decrease in matrix deposition of these proteins

reduced by Day 28 within human collagen cultures. IL‐8 release dras-

(Figure 6a) with a significant increase in their release into pooled

tically increased by Day 28 within rat collagen cultures compared with

media (Figure 6b), on a per cell basis, was noted over the 28‐day cul-

2D or human collagen cultures, and aza further enhanced these levels.

ture period. We further investigated the underlying mechanisms for

IP‐10 (CXCL10) was not expressed in any culture, except by spheroids

this paradox, that is, a time‐dependent reduction in protein deposition

FIGURE 6 Scatter plots showing mean and standard error of pooled ECM (total protein, sGAG, HA, and elastin) proteins deposited as matrix (a)
or released into pooled media (b), as quantified using various quantitative assays. Values were normalized to cell counts under respective culture
conditions, as indicated. Similarly, the levels of MMPs (c) and TIMPs (d) released by cells into pooled media and quantified by immuno‐beading
assays. Values were normalized to cell count in respective cases. From these plots, a significant negative linear correlation (R2 = .86) between
matrix protein deposition and culture duration, a significant positive linear correlation (R2 = .98) between protein release into pooled media and
culture duration, a significant positive linear correlation (R2 = .8) between MMPs released into pooled media and duration of culture, and a
significant downregulation (R2 = .8) of TIMPs release over the culture duration were noted. Schematic representation of the proposed competitive
inhibition mechanism (Alberts, 2004). (e) TIMPs block the binding site of MMPs and prevent it from binding with substrate (matrix protein). (f)
Equations (1)–(3) were fitted to the cumulative total protein deposition at each time point (experimental data pooled from across the cases) and
the resulting curve fitting of the model. Symbols represent the mean ± standard error of experimental data whereas dotted lines are the fitted
models [Colour figure can be viewed at wileyonlinelibrary.com]

as matrix despite their accumulation in pooled media (Figure 6a vs.

where EMMPs and ETIMPs are the concentrations of MMPs and TIMPs

Figure 6b). It turns out that the levels of matrix degrading enzymes

in nM respectively, t is the time in days, αMMPs and αTIMPs are produc-

(i.e., MMPs) increased significantly with time (Figure 6c), whereas the

tion rates (nM·day−1), and βMMPs and βTIMPs are the decay rate coeffi-

availability of matrix‐protecting enzymes (i.e., TIMPs) decreased in

cients of MMPs and TIMPs respectively (day−1). MMPs, released in an

these cultures (Figure 6d). The two groups of enzymes in this system

inactive form by eukaryotic cells, are usually activated and deactivated

(MMPs and TIMPs) were produced by cells, and although MMPs

by other MMPs and TIMPs respectively (e.g., MMPs 2 or 9 binds to

degrade matrix proteins, TIMPs supposedly inhibit them from

TIMP‐1 in 1:1 stoichiometry).
To model the protein concentration in this system, we used the

degrading matrix proteins.
As shown in Figure 6e, we assumed that (a) the production rate of
enzymes by cells is constant over time; (b) binding of MMPs to TIMPs

competitive inhibition form of Michaelis–Menten equation to estimate
the degradation rate of protein:

is reversible, as is binding of matrix protein molecules to MMPs; (c)
TIMPs and matrix protein substrate are homologous in binding affinity
and sites, and therefore compete to bind to free MMPs, leading to

dp
¼ αp −
dt


Km

kcat EMMPs p

;
½ETIMPs 
þp
1þ
kTIMPs

(3)

competitive inhibition; (d) either TIMP or matrix protein substrate
could bind effectively to MMPs, but not both together; and (e)

where p is the protein concentration, αp is the protein production rate

because matrix protein amounts are significantly higher than that of

(nM·day−1), kcat is the turnover number (day−1), Km is the Michaelis–

TIMPs (Figure 6), they might easily overcome the competition with

Menten constant (nM), and kTIMPs is the binding constant (nM) of

TIMPs. Equations 1 and 2 show the time‐dependent concentration

inhibitive enzyme (i.e., TIMPs). Again, we have assumed that the aver-

changes in MMPs and TIMPs over the 28‐day culture period:

age cellular production rate of protein, and other parameters in Equation 3, is constant over the 28 days of experiment. It should be noted

dEMMPs
¼ αMMPs − βMMPs EMMPs;
dt

(1)

dETIMPs
¼ αTIMPs − βTIMPs ETIMPs ;
dt

(2)

that such measured matrix protein amounts also include the intracellular proteins in respective cultures at these time points.
Experimental data from three time points, that is, Days 1, 12, and
28, were used to predict the protein concentration at intermediate

105.0607 ± 1.943

kTIMPs (nM)

time points. All simulations and optimization methods have been done
in Python using the numpy, lmfit, and scipy libraries and leastsq as a
fitting method. Curve‐fitting results (Table 1 and Figure 6f) suggest
an excellent match between the fitted model and the experimental
data. The fitted curves for MMPs, TIMPs, and protein concentrations
exhibited R2 ≥ 0.96 indicating the success of this model in describing

0.1357 ± 0.0063

km (nM)

the experimental data.
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DISCUSSION

Recently, MSCs have emerged as a primary candidate for cell‐based
20388.4 ± 107.9

kcat (day−1)

therapies, with around hundreds of clinical trials already conducted
to test their suitability in treating various ailments, including cardiovascular diseases (~14% of the total trials; Squillaro, Peluso, & Galderisi,
2016). The immense clinical potential of MSCs has been attributed
to their differentiability, immune‐suppression, anti‐apoptotic and
anti‐inflammatory roles, trophic and migration abilities to the
2.6165 ± 2E−10

βTIMPs(day−1)

injured/diseased tissues, and their ability to secrete multiple paracrine
factors essential for tissue regeneration (Murphy, Moncivais, & Caplan,
2013). These soluble paracrine factors serve as crucial mitogenic, pro‐
angiogenic, anti‐apoptotic, immunomodulatory, anti‐scarring, chemo‐
attractive,

and

supportive

factors

during

tissue

regeneration

1.5034 ± 2E−08

βMMPs (day−1)

MSCs also secrete various ECM proteins, proteases (MMPs), and their
inhibitors (TIMPs) that play crucial role in matrix rebuilding and remodelling (Williams & Hare, 2011). Thus, in recent years, there has been an
immense interest to unveil the vast repertoire of MSC secretome,
their mechanisms to induce tissue repair and regeneration, and

1.9301 ± 1E−10

αTIMPs (nM/day)

approaches to modulate such outcomes.
MSC secretome exerts both positive and negative effects on cardiac regeneration. For instance, eotaxins 1, 2, and 3 (CCL11, CCL24,
and CCL26, respectively) are involved in vascular diseases and endothelial dysfunction; MCP‐1 and IL‐1, 6, and 8 are pro‐inflammatory;
MMPs contribute to matrix degradation, whereas TGF‐β could lead

0.0042 ± 4E−11

αMMPs (nM/day)

to cardiac fibrosis (Williams & Hare, 2011). Thus, it is important to
not only promote beneficial paracrine factors release by MSCs but
also explore mechanisms to minimize the release of inhibitory factors
for better tissue regeneration outcomes. MSC secretome is also
responsive to the local micro‐environment cues; that is, inflammatory
cytokines stimulate MSCs to secrete higher amounts of growth factors

53.3657 ± 1.1863

αp (nM/day)

(Ma et al., 2014). Extrinsic techniques such as physiological preconditioning, gene manipulation, molecular and pharmaceutical preconditioning, cell–cell interactions, and physical pre‐conditioning are
needed to improve MSC survival post‐transplantation and achieve
controlled, predictable, and durable MSC secretome (Ranganath
et al., 2012).
Spheroid formation is important as MSCs within spheroids preserve phenotype and innate properties and lead to enhanced cell survival, differentiation, and regenerative potential, compared with loose
28 days

Culture period

TABLE 1

Model parameters obtained from curve fitting of Equations (1)–(3) to experimental data

(Meirelles, Fontes, Covas, & Caplan, 2009). Besides these cytokines,

MSCs (Sart, Tsai, Li, & Ma, 2013). Cells in spheroids coordinate with
each other and with the released secretome to result in higher cell–
cell and cell‐ECM interactions. In addition, cells also experience

gradients of physical tension, cytokines, nutrients, and oxygen tension

reported in 2D cultures of loose MSCs. In this study, the normalized

(e.g., mild hypoxia in the interior), and all these factors are hypothe-

released amounts of total protein, sGAG, HA, and elastin on 2D sub-

sized to precondition MSCs for enhanced secretion of pro‐angiogenic

strates by Day 12 were 106, 3,500, 60, and 2,700 pg, respectively,

and anti‐inflammatory factors and ECM molecules (Sart et al., 2013).

and by Day 28 were 35 × 104, 2,800, 52, and 3,600 pg, respectively.

Specifically, the hypoxic core of MSC spheroids upregulates hypoxia‐

Amable, Teixeira, Carias, Granjeiro, and Borojevic (2014) reported that

associated genes, which are principally regulated by hypoxia inducible

control BM‐MSCs in 2D cultures released <5 pg of collagen I, <50 pg

factor (HIF) master transcription factors (Cesarz & Tamama, 2016; Sart

of collagen II, <1,250 pg of collagen III, ~120 pg of elastin, ~300 pg of

et al., 2013). In hypoxic conditions, HIF‐1α and HIF‐2α exert crucial

heparin sulfate, <3 pg of decorin, <0.5 pg of aggrecan, and 4 pg of lam-

roles in MSC stemness and paracrine secretion, and the protein

inin, per million cells per day. These amounts are much lower com-

expression of both these transcription factors is observed in MSC

pared with the matrix protein levels noted in our study in 2D cultures

spheroids (Cesarz & Tamama, 2016; Sart et al., 2013). Thus, the hyp-

(Figure 2), which could be attributed to differences in loose (in their

oxic environment within MSC spheroids enhance pro‐angiogenic

study) versus spheroid cultures here.

growth factors (e.g., VEGF and HGF), upregulates anti‐inflammatory

Although cell proliferation and survival were compromised in 3D

molecules (e.g., PGE2, TSG‐6), and confers higher differentiation and

human collagen gels in our study, the normalized matrix amounts on

matrix synthesis ability of MSC spheroids, when compared with their

a per cell basis were significantly higher than in 2D TCP or 3D rat col-

loose counterparts (Bartosh et al., 2010; Cesarz & Tamama, 2016; Sart

lagen gels, even in aza‐free conditions. Similar trends were noted for

et al., 2013). Apart from HIF, anti‐apoptotic molecules such as Bcl‐2

collagen III, laminin, fibrillin, NOS2 (iNOS), and NOS3 (eNOS) levels

are upregulated in MSC spheroids that provide higher cell survival

in human collagen gel cultures. These native myocardial components

benefits post‐transplantation and higher regeneration ability to MSC

contribute to provide specific micro‐environment niche that influ-

spheroids (Bartosh et al., 2010; Cesarz & Tamama, 2016; Sart et al.,

ences the endogenous progenitor cell differentiation process (Bayomy,

2013). In this context, our prior study examined time‐dependent

Bauer, Qiu, & Liao, 2012). Thus, higher myocardial matrix components

cardiomyogenic evolution from human BM‐MSCs when MSC spher-

deposition by BM‐MSC spheroids, within 3D collagen gels and specif-

oids were cultured within 2 mg/ml (rat tail‐derived) collagen hydrogel

ically within human collagen, infer their higher potential in recovering

and treated with 10 μM aza for 28 days (Joshi et al., 2018). Delivering

lost tissue following MI. Aza exposure reduced the expression of most

such MSC‐loaded hydrogels to the infarct myocardium will influence

of the myocardial proteins within rat and human collagen gels that

cardiac regeneration because they (a) provide immediate micro‐

could boost its application in the treatment of cardiac fibrosis, as

environment for the transplanted cells and other newly infiltrated

DNA hypermethylation (for which aza is normally used) has been asso-

endogenous progenitor cells to home in and improve their cell survival,

ciated with many forms of cardiac fibrosis (Neary, Watson, & Baugh,

(b) deliver regenerative paracrine cargo that will awaken endogenous

2015). Thus, 3D collagen gels, specifically from human collagen, pro-

regeneration capability, and (c) replace the native lost cardiomyocytes

moted synthesis of cardiac matrix components; however, reduced

with cardiomyocyte‐like cells. However, it was not clear till now how

matrix synthesis with aza may refer to its anti‐fibrotic role.

this 3D milieu modulates the time‐dependent secretome release and

We noted that release of chemokines (IL‐6, MCP‐1, MCP‐3, and

ECM deposition by the BM‐MSC spheroids relevant for cardiac tissue

GRO‐α) and growth factors (FGF‐2 and VEGF‐α) reduced with spher-

regeneration.

oid formation and collagen cultures; human collagen and aza lowered

Two‐way ANOVA analysis suggested that culture condition (scaf-

chemokines release but promoted higher iNOS expression, a potent

fold type and aza treatment, p < .0001), culture duration (p = .0004),

immunomodulatory factor. Because higher levels of chemokines in

and the interaction of these two factors (p < .0001) exerted significant

serum was detected in patients with heart diseases (Dusi, Ghidoni,

roles on cell proliferation. In addition, significant effects of culture

Ravera, De Ferrari, & Calvillo, 2016), the reduced levels of chemokines

condition (p < .0001) and culture duration (p = .002) on cell viability

noted in our study could be beneficial in limiting the tissue inflamma-

were noted, with rat collagen gels supporting significantly higher via-

tion of an inflamed myocardial micro‐environment. Thus, collagen cul-

bility compared with human collagen gels at each culture duration, in

tures and specifically human collagen led to reduced expression of

the presence or absence of aza (p < .001 for all cases). Taken together,

chemokines and pro‐inflammatory cytokines but caused concomitant

results indicate benefits of rat collagen gels for cell proliferation and

higher expression of immunomodulatory factor; such tuned MSC pro-

viability compared with human collagen gels. Normalized total protein,

file could be beneficial when administered to inflamed myocardium.

elastin, LOX, HA, and sGAG amounts, either deposited as matrix or

Significant reduction in the deposition of elastin, sGAG, and HA

released into pooled media, were significantly influenced by culture

proteins within 2D cultures, from Day 12 to Day 28, could be due to

conditions, duration, and interaction of these two factors (p < .0001,

concomitant increases in MMP‐2 release over this duration. Com-

for all). For reasons beyond the scope of this work, human collagen

pared with 2D cultures, 3D collagen gels appear to have promoted

appeared to promote significantly higher release of most of these pro-

higher secretion of cardiac tissue‐relevant ECM proteins over the 28

teins compared with 2D cultures or rat collagen, whereas aza sup-

days. We earlier reported that MSC spheroids within 2 mg/ml rat col-

pressed the amounts of these proteins in most cases.

lagen gels (with 10 μm aza) expressed early cardiomyocyte‐like pheno-

On a per cell basis, the matrix amounts in 2D MSC spheroid cul-

type by Day 12 and late cardiomyocyte‐like phenotype by Day 28

tures (Figure 2d) noted in our study were significantly higher than that

(Joshi et al., 2018). Thus, the differentiated cells within 3D collagen

gels could be synthesizing and depositing more ECM proteins than

was reported to be 5 × 10−5/s (Kim & Friedman, 2010), which closely

their undifferentiated counterparts in 2D cultures. Although spheroid

match the degradation rate (βMMPs) derived in our simulations

cultures in human collagen gels (with 10 μM aza) promoted synthesis

(Table 1). Because our model was trained on experimental observa-

and release of sGAG, tropoelastin, HA, and LOX from Days 12 to 28,

tions, and there is a lack of pertinent literature on absolute values of

their deposition as matrix proteins was not proportionally realized. In

production and decay rates of proteins and enzymes by mammalian

general, 2D cultures promoted release of cardiac matrix proteins

cells (not their rate constants) or kinetics model parameters (Km, Kcat,

mostly until Day 12, whereas 3D collagen gels (rat or human) pro-

and KTIMPs), our modelling results need to be verified independently

moted release of such matrix proteins by differentiated cells, espe-

by others. Although several important parameters were deduced by

cially from Days 12 to 28.

developing a mathematical model that represents the experiments,

Collagen from different tissues undergo a series of unique post‐

more work is needed to elucidate the variability in protein production

translational modifications that will govern the spatial organization,

dynamics in stem cell versus mature cardiomyocyte cultures and

diameter, cross‐linking, and D‐spacing of the collagen fibrils (Fang &

across various time segments.

Holl, 2013). In addition, the processing conditions, such as tempera-

In conclusion, our study reports for the first time on secretome

ture, pH, ionic strength, enzyme treatment, and the initial raw material,

release and ECM deposition and turnover in human BM‐MSC spher-

are known to influence collagen functional properties such as gelation

oids within 3D collagen (rat and human), even in the presence of

rate, viscosity, and water retention capacity (Schmidt et al., 2016).

aza, over 28 days. We developed a mathematical model to understand

Because collagen from rat‐tail tendon is less cross‐linked and more

the protein synthesis and deposition dynamics within these 28‐day

pure, dilute acid extraction is typically performed that retains the

cultures and quantitatively assessed the critical role of MMP‐TIMP

molecular domains of the collagen molecules. On the other hand, for

nexus. Successful clinical application of autologous BM‐MSCs for MI

collagen

treatment is contingent not only on maximizing efficiency of cardio-

(Vitrocol®), enzymatic treatment is done, which cleaves telopeptides

myocyte differentiation and maturation but also on modulating cell

collagens

with

higher

cross‐links,

including

human

of collagen molecules (Kanta, 2015; Schmidt et al., 2016).

secretome and MMPs‐mediated ECM turnover. For effective clinical

Telopeptides principally participate in the intermolecular cross‐links

translation, further studies are needed to examine and compare the

and impact the physical, biochemical, and mechanical properties of

matrix synthesis and paracrine secretion ability of human MSCs,

the hydrogels (Kanta, 2015; Schmidt et al., 2016). In addition,

MSC spheroids, differentiated cardiomyocyte‐like MSCs, and mature

telopeptides are major antigenic determinants (Gorgieva & Kokol,

cardiomyocytes, over longer culture durations within both in vitro

2011); removal of telopeptides in human collagen eliminates the

and in vivo conditions.

chances of immunogenic responses, if any, with the allogeneic collagen usage. Thus, differences in their extraction process could influ-
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processing states for rat and human collagens could have uniquely
contributed to the observed MSC survival and functional responses.
We report here (for the first time) on the utility of a competitive
inhibition form of Michaelis–Menten equation to estimate the degradation rate of a mixture of proteins in long‐term stem cell cultures.
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